.After antibody-drug conjugate (ADC) expert Seagen was sold to Pfizer in 2015 for a monstrous $43 bi...
.On the heels of a phase 3 succeed that fell short to excite clients, Ironwood Pharmaceuticals is ba...
.Do not cease Monte Rosa Rehabs now. The Boston-based biotech is having a ball after signing a take ...
.Invite to this week's Chutes & Ladders, our roundup of substantial leadership hirings, shootings...
.Celebrating his company's upsized going public (IPO), Septerna chief executive officer Jeffrey Fine...
.AbbVie has actually returned to the resource of its antipsychotic giant Vraylar trying to find anot...
.GenSight Biologics is actually full weeks out of losing funds. Once more. The biotech only possesse...
.Monopar Therapeutics is actually recovering a medicine coming from the dump of AstraZeneca's unusua...
.With brand new information out on Arcus Biosciences' experimental HIF-2a prevention, one team of pr...
.After creating a genetics treatment alliance along with Dyno Therapeutics in 2020, Roche is actuall...